A meta-analysis of 39 studies comparing PCT and CRP revealed that the mean sensitivity of early-onset sepsis (EOS), late-onset sepsis (LOS), and both EOS and LOS combined are 73.6%, 88.9%, and 76.5% respectively suggesting that procalcitonin is superior to CRP. The gene discussed is CRP; the disease is Sepsis.